Dopamine stimulates vasopressin (AVP) secretion when applied to the incubation medium of the isolated rat hypothalamic tissue (1) , and enhances plasma AVP concentration when given intracerebroventricularly (icv) in conscious rats (2) (3) (4) (5) (6) . However, location in the brain of dopamine receptors contributing to facilitation of AVP release remains uncertain. It is possible to presume two periventricular regions as the candidate for the locus. One is the region surrounding the anteroven¬ tral third ventricle (AV3 V) which is known as a primary reception site for angiotensin II and an osmotic stimulus (7) (8) (9) . The conceivable role of dopamine receptors in this area can be speculated from the observations that the AV3V region contains dopaminergic fibers and dopa¬ mine sensitive neurons (10, 11) which may be involved in the regulation of water balance, and that the inhibitory effects of electrical or chemical destruction of the AV3 V region on the angiotensin II-and the hyperosmolality-induced AVP release (12) (13) (14) (15) (16) could be mimicked by the icv administration of the antagonists (3) (4) (5) (6) which may block dopamine receptors in the AV3V region. The (Fig. 2, D and E) , applications of 26 nmol dopamine caused remarkable augmentations of plasma AVP 5 and 15 min later (Fig. 1, bottom panel) (Fig. 2, A-C (Fig. 1) . Since it has been indicated that PVN administration of dopamine could enhance firing rates in some neurosecretory cells (22) (Fig. 2) (Fig. 1 ) . Consider¬ ing that dopamine was without effect when the injection sites deviated from the PVN, the possibility that dopa¬ mine diffused from the PVN was responsible for the AVP response could be eliminated.
The AV3V region (a primary reception site for angio¬ tensin II and an osmotic stimulus) receives afférents from the subfornical organ (the other reception site for these factors) and from the areas related to regulation of the cardiovascular system (15, 27) , and projects efferents to the PVN, SON and the median preoptic nucleus (15) where synapses to these nuclei were located (28) (29) (30) (11) and dopaminergic fibers (10) . Alternatively, the used dose (26 nmol) of dopamine might not have been large enough to activate the receptors involved in AVP release, although it was sufficiently effective in the case of the PVN administration (Fig. 1) . The 
